LLY announcements Eli Lilly And Company announcements and dividends declared USA
Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY
Eli Lilly And Company LLY listed on USA and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Eli Lilly And Company LLY
: Eli Lilly’s tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in late-stage trial
Eli Lilly & Co. LLY said Thursday its tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in a late-stage trial. Participants in the phase 3 trial called Surmount-2 lost up to 34.4 pounds, the company said
Announcement as on 27 April 2023
Eli Lilly's new obesity drug helped patients lose up to 34 pounds in trials
Eli Lilly's new obesity drug helped patients lose up to 34 pounds in trials
Announcement as on 27 April 2023
: Eli Lilly to sell hypoglycemia treatment for up to .1 billion in cash and milestone payments to Amphastar
Shares of Eli Lilly & Co. LLY gained 0.5% in premarket trading Monday, after the drugmaker announced an agreement to sell its hypoglycemia treatment for people with diabetes Baqsimi to Amphastar Pharmaceuticals Inc. AMPH for up to .075 billion in cash an
Announcement as on 24 April 2023
: Eli Lilly to invest another .6 billion, add 200 more jobs to its new manufacturing sites in Indiana
Eli Lilly & Co. LLY said Monday that it will invest an additional .6 billion into its two new manufacturing sites in Indiana, creating an additional 200 jobs. That will bring the drug maker’s total investment at its sites within the LEAP Innovation Par
Announcement as on 17 April 2023
Morgan Stanley Maintains Eli Lilly And (LLY) Overweight Recommendation
Fintel reports that on April 10, 2023, Morgan Stanley maintained coverage of Eli Lilly And (NYSE:LLY) with a Overweight recommendation.
Announcement as on 11 April 2023
Announcements by Eli Lilly And Company first page | Next page | Prev page |
LLY Eli Lilly And Company current price & indicator signals
Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 23 Thu Apr 2026 | 917.65 | 911.89 to 930.00 | -0.42% | 0.92 times |
| 22 Wed Apr 2026 | 921.48 | 902.23 to 922.54 | 2.04% | 1.12 times |
| 21 Tue Apr 2026 | 903.02 | 881.11 to 913.05 | -1.83% | 1.74 times |
| 20 Mon Apr 2026 | 919.90 | 912.50 to 929.64 | -0.77% | 0.83 times |
| 17 Fri Apr 2026 | 927.03 | 917.80 to 929.99 | 2.61% | 1.4 times |
| 16 Thu Apr 2026 | 903.43 | 898.15 to 920.00 | -0.18% | 0.58 times |
| 15 Wed Apr 2026 | 905.03 | 888.03 to 930.00 | -1.94% | 1.81 times |
| 14 Tue Apr 2026 | 922.89 | 915.04 to 939.93 | -0.72% | 0.53 times |
| 13 Mon Apr 2026 | 929.55 | 927.17 to 945.90 | -1.07% | 0.9 times |
| 10 Fri Apr 2026 | 939.57 | 935.54 to 963.94 | -1.64% | 0.38 times |
| 09 Thu Apr 2026 | 955.19 | 939.29 to 963.76 | 0.2% | 0.72 times |
| 08 Wed Apr 2026 | 953.30 | 933.13 to 961.14 | 2.41% | 1.1 times |
Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared USA
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


